Volume 63, Issue 3, Pages (March 2003)

Slides:



Advertisements
Similar presentations
The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: A potential mechanism for senescence in.
Advertisements

Osmotic pressure of gingiva in periodontitis: Correlation with gingival proinflammatory cytokine production and alveolar bone destruction  Müge Lütfioğlu,
Cellular mechanisms of renal osteodystrophy
Zhao Jing, M. D. , Zhang Qiong, M. D. , Wang Yonggang, M. D
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
The Th17 immune response in renal inflammation
Quiz Page March 2008 American Journal of Kidney Diseases
Volume 54, Issue 4, Pages (October 1998)
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Yiping Wang, Yuet-Ching Tay, David C.H. Harris  Kidney International 
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 63, Pages S88-S90 (June 2003)
Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy  David Soriano, M.D., Danielle.
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury  Lihong Fan, MD, Kunzheng.
Volume 53, Issue 4, Pages (April 1998)
EGFR signaling in renal fibrosis
Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model  Qiong-Hua Chen, Ph.D., Wei-Dong Zhou,
The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: A potential mechanism for senescence in.
Volume 69, Issue 7, Pages (April 2006)
Volume 85, Issue 3, Pages (March 2014)
Volume 81, Issue 3, Pages (February 2012)
Insulin resistance in African Americans
High Invasive Melanoma Cells Induce Matrix Metalloproteinase-1 Synthesis in Fibroblasts by Interleukin-1α and Basic Fibroblast Growth Factor-Mediated.
Use of vitamin D in chronic kidney disease patients
The role of protein kinase C activation in diabetic nephropathy
Cell biology of the osteoclast
Volume 56, Issue 5, Pages (November 1999)
Claudine S. Bonder, Lisa M. Ebert  Kidney International 
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Cytokine gene polymorphisms and severity of CF lung disease
Blood pressure targets in hemodialysis patients
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria  Kai-Hsin Chang, Mary M. Stevenson  Kidney International 
Volume 56, Issue 2, Pages (August 1999)
Volume 54, Issue 4, Pages (October 1998)
Volume 79, Issue 2, Pages (January 2011)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 70, Issue 8, Pages (October 2006)
Nephrology in Latin America, with special emphasis on Brazil
Volume 87, Issue 3, Pages (March 2015)
Volume 68, Issue 5, Pages (November 2005)
Volume 73, Issue 6, Pages (March 2008)
Why is proteinuria an ominous biomarker of progressive kidney disease?
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 5, Pages (November 2000)
D. Fuster, A. Monegal, J.-V. Torregrosa  Kidney International 
Volume 57, Issue 6, Pages (June 2000)
Volume 61, Issue 3, Pages (March 2002)
Volume 72, Issue 11, Pages (December 2007)
Volume 68, Pages S98-S102 (December 2005)
Molecular and structural consequences of early renal allograft injury
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 66, Issue 6, Pages (December 2004)
Volume 86, Issue 5, Pages (November 2014)
Toward a B-cell signature of tolerance?
The Case | Peculiar fibrous nodules in a renal transplant biopsy
Volume 75, Issue 5, Pages (March 2009)
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Adiponectin: good, bad, or just plain ugly?
Volume 75, Issue 6, Pages (March 2009)
Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor  Senthilkumar Alagesan, Matthew D. Griffin 
The ins and outs of phosphate homeostasis
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Volume 75, Issue 8, Pages (April 2009)
Volume 87, Issue 6, Pages (June 2015)
Volume 74, Pages S4-S9 (December 2008)
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Volume 63, Issue 3, Pages 899-907 (March 2003) IL-1β, TNF-α, TGF-β, and bFGF expression in bone biopsies before and after parathyroidectomy  Francisco R. Lello Santos, Rosa M.A. Moysés, Fábio L.M. Montenegro, Vanda Jorgetti, Irene L. Noronha  Kidney International  Volume 63, Issue 3, Pages 899-907 (March 2003) DOI: 10.1046/j.1523-1755.2003.00835.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Immunohistochemistry for cytokines and growth factors in bone biopsies. Positive staining appears as brown color (×100). (A) Interleukin-1β (IL-1β) expression in medullar fibrosis and resorption areas in a patient with severe hyperparathyroidism (HPT). (B) After parathyroidectomy (PTX), only a discrete positivity for IL-1β is observed. (C) Tumor necrosis factor-α (TNF-α) expression in resorptive lacunae before PTX. (D) Almost no TNF-α staining after PTX. (E) Intense immunostaining for transforming growth factor-β (TGF-β) in the fibrous area adjacent to the cellular tissue. (F) After PTX, a very weak immunostaining for TGF-β is observed. (G) basic fibroblast growth factor (bFGF) in the fibrotic marrow replacement of the normal bone marrow tissue before PTX. (H) Weak staining for bFGF in osteoid surface after PTX. Kidney International 2003 63, 899-907DOI: (10.1046/j.1523-1755.2003.00835.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Quantitative expression of interleukin-1β (IL-1β) (A), tumor necrosis factor-α (TNF-α) (B), transforming growth factor-β (TGF-β) (C), andbasic fibroblast growth factor (bFGF) (D) (%) of cytokines and growth factors in bone biopsies before and 1 year after parathyroidectomy (PTX). *P < 0.001 vs. before PTX; #P < 0.05 vs. after PTX. Kidney International 2003 63, 899-907DOI: (10.1046/j.1523-1755.2003.00835.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Correlation between interleukin-1β (IL-1β) (A), tumor necrosis factor-α (TNF-α) (B), transforming growth factor-β (TGF-β) (C), andbasic fibroblast growth factor (bFGF) (D) expression in bone biopsies with intact parathyroid (iPTH) levels before (○) and one year after (•) parathyroidectomy (PTX). Kidney International 2003 63, 899-907DOI: (10.1046/j.1523-1755.2003.00835.x) Copyright © 2003 International Society of Nephrology Terms and Conditions